SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.

Press Releases Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Equities

002399

CNE100000P02

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
10.36 ^CNY	+9.98%		+12.36%	-11.68%

Apr. 29	Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Shenzhen Hepalink Receives Thai Approval for Blood Clot Drug Exarane	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shenzhen Hepalink Pharmaceutical : RESIGNATION OF VICE CHAIRMAN AND EXECUTIVE DIRECTOR	21-05-06	PU
Shenzhen Hepalink Pharmaceutical : PROXY FORM FOR THE 2020 ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, MAY 26, 2021 (OR ANY ADJOURNMENT THEREOF)	21-04-22	PU
Shenzhen Hepalink Pharmaceutical : NOTICE OF THE 2020 ANNUAL GENERAL MEETING	21-04-22	PU
Shenzhen Hepalink Pharmaceutical : 2020 AGM Circular	21-04-22	PU
Shenzhen Hepalink Pharmaceutical : VOLUNTARY ANNOUNCEMENT"HEPTRIS" OBTAINS APPROVAL FROM BRAZILIAN HEALTH REGULATORY AGENCY	21-04-21	PU
Shenzhen Hepalink Pharmaceutical : (1) RESIGNATION OF NON-EXECUTIVE DIRECTOR (2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR	21-04-20	PU
Shenzhen Hepalink Pharmaceutical : VOLUNTARY ANNOUNCEMENT - "INHIXA" OBTAINS APPROVAL FROM NORTH MACEDONIA	21-04-13	PU
Shenzhen Hepalink Pharmaceutical : VOLUNTARY ANNOUNCEMENT SETTLEMENT OF THE DISPOSAL OF SHARES OF KYMAB	21-04-09	PU
Shenzhen Hepalink Pharmaceutical : "ENOXAPARIN SODIUM INJECTION" OBTAINS APPROVAL FROM FDA	20-09-21	PU
Shenzhen Hepalink Pharmaceutical : CHANGE OF JOINT COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES	20-09-18	PU
Shenzhen Hepalink Pharmaceutical : CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG	20-09-11	PU
Shenzhen Hepalink Pharmaceutical : POLL RESULTS OF THE 2020 THIRD EXTRAORDINARY GENERAL MEETING HELD ON AUGUST 31, 2020	20-08-31	PU
Shenzhen Hepalink Pharmaceutical : Hepalink Announces 2020 Interim Results	20-08-30	AQ
Shenzhen Hepalink Pharmaceutical : PROXY FORM FOR THE 2020 THIRD EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, AUGUST 31, 2020 (OR ANY ADJOURNMENT THEREOF)	20-08-10	PU
Shenzhen Hepalink Pharmaceutical : RE-ELECTION OF DIRECTORS OF THE FIFTH SESSION OF THE BOARD RE-ELECTION OF SUPERVISORS OF THE FIFTH SESSION OF THE SUPERVISORY COMMITTEE REMUNERATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS OF THE FIFTH SESSION OF THE BOARD CREDIT LINE APPLICATION AND PROVISION OF GUARANTEE AMENDMENT OF THE ARTICLES OF ASSOCIATION AND NOTICE OF THE 2020 THIRD EXTRAORDINARY GENERAL MEETING	20-08-10	PU
Shenzhen Hepalink Pharmaceutical : NOTICE OF THE 2020 THIRD EXTRAORDINARY GENERAL MEETING	20-08-10	PU
Shenzhen Hepalink Pharmaceutical : RE-ELECTION OF DIRECTORS OF THE FIFTH SESSION OF THE BOARD, RE-ELECTION OF SUPERVISORS OF THE FIFTH SESSION OF THE SUPERVISORY COMMITTEE AND AMENDMENT OF THE ARTICLES OF ASSOCIATION	20-07-31	PU
Shenzhen Hepalink Pharmaceutical : STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF THE OVER-ALLOTMENT OPTION	20-07-30	PU
Shenzhen Hepalink Pharmaceutical : Hepalink Announces Exciting Regulatory Developments	20-06-28	BU
Shenzhen Hepalink Pharmaceutical : Hepalink Announces the Appointment of Healthcare Senior Executive Mr. Frank Sun as Executive Director and Vice Chairman of the Board	20-03-05	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Equities

002399

CNE100000P02

Press Releases

Filters